Search research articles
Contact Us
Filters
Showing results (1-10 of 84) with videos related to
Page
of 9
Sort By:
International Journal of Hematology
|
January 7, 2003
Monoclonal antibody therapy for B-cell lymphoma
Antonio J Grillo-López
Seminars in Oncology
|
March 24, 2005
90Y-ibritumomab tiuxetan: rationale for patient selection in the treatment of indolent non-Hodgkin's lymphoma
Antonio J Grillo-López
Expert Review of Anticancer Therapy
|
December 23, 2003
Rituximab (Rituxan/MabThera): the first decade (1993-2003)
Antonio J Grillo-López
Expert Review of Anticancer Therapy
|
April 9, 2013
The first antibody therapy for cancer: a personal experience
Antonio J Grillo-López
Expert Review of Anticancer Therapy
|
October 18, 2002
Zevalin: the first radioimmunotherapy approved for the treatment of lymphoma
Antonio J Grillo-López
Expert Review of Anticancer Therapy
|
July 13, 2002
AntiCD20 mAbs: modifying therapeutic strategies and outcomes in the treatment of lymphoma patients
Antonio J Grillo-López
Seminars in Oncology
|
February 28, 2001
Rituximab: an insider's historical perspective
A J Grillo-López
Hospital Materiel Management Quarterly
|
October 6, 1991
Spotlight on rehabilitation
H Brodsky, J Frumenti, J Grillo
Environmental Health Perspectives
|
June 1, 1997
The relationship between selected causes of postneonatal infant mortality and particulate air pollution in the United States
T J Woodruff, J Grillo, K C Schoendorf
The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons
|
July 1, 1993
Silicone implant arthroplasty: a retrospective analysis
V J Hetherington, C Mercado, L Karloc, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 84) with videos related to
Sort By:
Page
of 9
International Journal of Hematology
|
January 7, 2003
Monoclonal antibody therapy for B-cell lymphoma
Antonio J Grillo-López
Seminars in Oncology
|
March 24, 2005
90Y-ibritumomab tiuxetan: rationale for patient selection in the treatment of indolent non-Hodgkin's lymphoma
Antonio J Grillo-López
Expert Review of Anticancer Therapy
|
December 23, 2003
Rituximab (Rituxan/MabThera): the first decade (1993-2003)
Antonio J Grillo-López
Expert Review of Anticancer Therapy
|
April 9, 2013
The first antibody therapy for cancer: a personal experience
Antonio J Grillo-López
Expert Review of Anticancer Therapy
|
October 18, 2002
Zevalin: the first radioimmunotherapy approved for the treatment of lymphoma
Antonio J Grillo-López
Expert Review of Anticancer Therapy
|
July 13, 2002
AntiCD20 mAbs: modifying therapeutic strategies and outcomes in the treatment of lymphoma patients
Antonio J Grillo-López
Seminars in Oncology
|
February 28, 2001
Rituximab: an insider's historical perspective
A J Grillo-López
Hospital Materiel Management Quarterly
|
October 6, 1991
Spotlight on rehabilitation
H Brodsky, J Frumenti, J Grillo
Environmental Health Perspectives
|
June 1, 1997
The relationship between selected causes of postneonatal infant mortality and particulate air pollution in the United States
T J Woodruff, J Grillo, K C Schoendorf
The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons
|
July 1, 1993
Silicone implant arthroplasty: a retrospective analysis
V J Hetherington, C Mercado, L Karloc, et al.
Page
of 9